A carregar...
Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson’s disease
Several selective antagonists for adenosine A(2A) receptors (A(2A)R) are currently under evaluation in clinical trials (phases I to III) to treat Parkinson’s disease, and they will probably soon reach the market. The usefulness of these antagonists has been deduced from studies demonstrating functio...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3205226/ https://ncbi.nlm.nih.gov/pubmed/21810444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2011.07.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|